IceCure Medical Ltd. (ICCM) - Dilution Analysis

F-1 filing: This F-1 filing relates to the resale of up to 16,000,000 Ordinary Shares by selling shareholders, including shares issuable upon the exercise of Series B and Series C warrants.

F-3 filing: IceCure Medical Ltd. may offer and sell up to $100,000,000 of its ordinary shares, warrants, or units comprising a combination of ordinary shares and warrants from time to time.

POS AM filing: The company is removing from registration six Units, consisting of six Ordinary Shares and Warrants to purchase up to six Ordinary Shares, together with such indeterminate number of Ordinary Shares as may have become issuable upon exercise of the Warrants registered pursuant to Rule 416 under the Securities Act of 1933, as amended, that were registered but unsold.

RW filing: The Company has determined not to pursue, at this time, the public offering to which the Registration Statement relates and withdrawal of the Registration Statement is consistent with the public interest.

F-1 filing: IceCure Medical Ltd. is conducting a rights offering to distribute subscription rights to holders of ordinary shares, offering units consisting of ordinary shares and warrants, and pre-funded warrants in lieu of ordinary shares for certain purchasers, with Maxim Group LLC acting as the dealer-manager.

20-F filing | 56.6M shares outstanding

20-F filing | 56.6M shares outstanding

F-1 filing: IceCure Medical Ltd. is offering ordinary shares, warrants to purchase ordinary shares, and pre-funded warrants to purchase ordinary shares on a best efforts basis, as detailed in the F-1 filing dated 2024-10-15.

20-F filing | 45.6M shares outstanding

20-F filing | 45.6M shares outstanding

POS AM filing: This is a POS AM filing for IceCure Medical Ltd. relating to the resale of up to 8,079,145 ordinary shares by selling shareholders.

F-3 filing: IceCure Medical Ltd. intends to offer and sell up to $100,000,000 of its ordinary shares, warrants, or units comprising a combination of ordinary shares and warrants from time to time in one or more offerings.

POS AM filing: IceCure Medical Ltd. is offering up to 1,034,000 ordinary shares upon the exercise of pre-funded warrants to purchase 1,034,000 Ordinary Shares. The exercise price of each pre-funded warrant is $0.001 per share.

POS AM filing: This prospectus relates to the resale, by the selling shareholders, of up to 8,079,145 ordinary shares of IceCure Medical Ltd.

20-F filing | 35.8M shares outstanding

POS AM filing: This is a POS AM filing for IceCure Medical Ltd. relating to the resale of up to 8,036,673 ordinary shares by selling shareholders. The company will not receive any proceeds from the sale.

F-1 filing: IceCure Medical Ltd. is offering up to 3,067,485 ordinary shares, no par value. The Ordinary Shares are listed on the Nasdaq Capital Market under the symbol "ICCM." The last reported sale price on Nasdaq of the Ordinary Shares on December 1, 2021 was $4.89 per share.

POS AM filing: This prospectus relates to the resale, by the selling shareholders identified in this prospectus of up to 11,311,111 ordinary shares, no par value, or Ordinary Shares.

F-1 filing: This F-1 filing relates to the resale of up to 11,485,697 ordinary shares by the selling shareholders.